These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Barley beta-glucan lowers serum cholesterol based on the up-regulation of cholesterol 7alpha-hydroxylase activity and mRNA abundance in cholesterol-fed rats.
    Author: Yang JL, Kim YH, Lee HS, Lee MS, Moon YK.
    Journal: J Nutr Sci Vitaminol (Tokyo); 2003 Dec; 49(6):381-7. PubMed ID: 14974727.
    Abstract:
    Barley, which is high in soluble dietary fiber (particularly beta-glucan), is thought to have hypocholesterolemic effects. The present study was performed to further elucidate the hypocholesterolemic actions of waxy barley, and the extent to which they can be attributed to beta-glucan. Male Sprague-Dawley rats (n=21) were fed control (fiber-free) diets, diets with the addition of 2.5%, refined beta-glucan or 30% waxy barley that provides approximately 2.5% beta-glucan in the diet for 2 wk. Body weight gain and food efficiency of rats were unaffected by diet. beta-glucan or waxy barley decreased serum levels of total cholesterol (p < 0.05) by 13.5% or 18.9%, and also decreased LDL-cholesterol 19.4% or 24.3%, respectively. Addition of refined beta-glucan or waxy barley to the diet resulted in greater bile acid excretions (p < 0.05) compared to the control group. The waxy barley diet up-regulated by 2. 3 times and the beta-glucan diet by 1.5 times the activity of cholesterol 7a-hydroxylase (CYP7A1). Hepatic CYP7A1 mRNA level paralleled the increases in enzyme activity. The results of this study suggest that the hypocholesterolemic effects of both beta-glucan and a waxy barley diet may be due to the enhancement of CYP7A1 expression resulting from increased fecal excretion of bile acids.
    [Abstract] [Full Text] [Related] [New Search]